Kyntra Bio, Inc. (KYNB) stock
KYNBNasdaqPharmaceutical PreparationsFiscal year ends December 31
$3.44−0.15 (-4.18%)
Close on Nov 13, 2026Market cap $13.93MP/E 0.1Yield –
Kyntra Bio enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Kyntra Bio's enterprise value was -$76.42M on Nov 11, 2026, against -$82.38M a year earlier. Over the last 5 years it ranged from -$282.59M to $1.83B, with a median of -$56.67M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | -$76.42M | – |
| 2025 | Dec 31, 2025 | -$82.46M | – |
| 2024 | Dec 31, 2024 | -$77.65M | – |
| 2023 | Dec 29, 2023 | -$164.18M | -114.7% |
| 2022 | Dec 30, 2022 | $1.12B | +32.9% |
| 2021 | Dec 31, 2021 | $840.05M | -68.9% |
| 2020 | Dec 31, 2020 | $2.70B | -13.7% |
| 2019 | Dec 31, 2019 | $3.13B | -4.9% |
| 2018 | Dec 31, 2018 | $3.29B | +4.0% |
| 2017 | Dec 29, 2017 | $3.17B | +181.0% |
| 2016 | Dec 30, 2016 | $1.13B | -32.6% |
| 2015 | Dec 31, 2015 | $1.67B | +488.4% |
| 2014 | Dec 31, 2014 | $284.17M | – |
See a number that looks wrong?